Cargando…

Safety of new medicines in young children

Detalles Bibliográficos
Autor principal:	Choonara, Imti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Group 2011
Materias:	Drug Therapy
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198508/ https://www.ncbi.nlm.nih.gov/pubmed/21836178 http://dx.doi.org/10.1136/archdischild-2011-300450

Ejemplares similares

Systematic review of the toxicity of short-course oral corticosteroids in children
por: Aljebab, Fahad, et al.
Publicado: (2016)

Ciprofloxacin safety in paediatrics: a systematic review
por: Adefurin, Abiodun, et al.
Publicado: (2011)

Inter-individual variation in midazolam clearance in children
por: Altamimi, Mohammed I, et al.
Publicado: (2015)

Rational prescribing is important in all settings
por: Choonara, Imti
Publicado: (2013)

Observational study on the palatability and tolerability of oral prednisolone and oral dexamethasone in children in Saudi Arabia and the UK
por: Aljebab, Fahad, et al.
Publicado: (2018)

Paediatric clinical pharmacology in the UK
por: Choonara, Imti, et al.
Publicado: (2014)

How safe is paracetamol?
por: Star, Kristina, et al.
Publicado: (2015)

Safety of ceftriaxone in paediatrics: a systematic review
por: Zeng, Linan, et al.
Publicado: (2020)

Lack of a significant change in caffeine metabolism in underweight children as determined by the caffeine breath test
por: Oshikoya, K A, et al.
Publicado: (2015)

Pharmacokinetics and safety/tolerability of isoniazid, rifampicin and pyrazinamide in children and adolescents treated for tuberculous meningitis
por: Ruslami, Rovina, et al.
Publicado: (2022)

Pharmacokinetic studies in children: recommendations for practice and research
por: Barker, Charlotte I S, et al.
Publicado: (2018)

Acceptability of different oral formulations in infants and preschool children
por: van Riet-Nales, Diana A, et al.
Publicado: (2013)

Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects
por: van Riet-Nales, Diana A, et al.
Publicado: (2016)

Drug use and upper gastrointestinal complications in children: a case–control study
por: Bianciotto, Manuela, et al.
Publicado: (2013)

Neonatal outcomes following new reimbursement limitations on palivizumab in Italy
por: Belleudi, Valeria, et al.
Publicado: (2018)

Drug treatment of inborn errors of metabolism: a systematic review
por: Alfadhel, Majid, et al.
Publicado: (2013)

Biosimilar infliximab use in paediatric IBD
por: Richmond, Lisa, et al.
Publicado: (2018)

Predictors of intravenous amiodarone induced liver injury
por: Diab, O.A., et al.
Publicado: (2017)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

PCSK9 Monoclonal Antibodies: An Overview
por: Kaddoura, Rasha, et al.
Publicado: (2020)

Can parents believe websites’ information about methylphenidate’s side effects?
por: Arsac England, Tom, et al.
Publicado: (2021)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
por: Ortiz-Gracia, Alba, et al.
Publicado: (2022)

Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023)

Efficacy and Safety of Insulin Glargine 300 Units/mL (Gla-300) Versus Insulin Glargine 100 Units/mL (Gla-100) in Children and Adolescents (6–17 years) With Type 1 Diabetes: Results of the EDITION JUNIOR Randomized Controlled Trial
por: Danne, Thomas, et al.
Publicado: (2020)

Efficacy and Safety of Once-Weekly Efpeglenatide Monotherapy Versus Placebo in Type 2 Diabetes: The AMPLITUDE-M Randomized Controlled Trial
por: Frias, Juan Pablo, et al.
Publicado: (2022)

Why do young children die in the UK? A comparison with Sweden
por: Tambe, Parag, et al.
Publicado: (2015)

The Impact of Frailty on the Effectiveness and Safety of Intensive Glucose Control and Blood Pressure–Lowering Therapy for People With Type 2 Diabetes: Results From the ADVANCE Trial
por: Nguyen, Tu N., et al.
Publicado: (2021)

Efficacy and Safety of Liraglutide 3.0 mg in Individuals With Overweight or Obesity and Type 2 Diabetes Treated With Basal Insulin: The SCALE Insulin Randomized Controlled Trial
por: Garvey, W. Timothy, et al.
Publicado: (2020)

Dalcetrapib Reduces Risk of New-Onset Diabetes in Patients With Coronary Heart Disease
por: Schwartz, Gregory G., et al.
Publicado: (2020)

Why children do not receive treatment
por: Choonara, Imti
Publicado: (2014)

Anti-Epileptic Drug Toxicity in Children
por: Choonara, Imti
Publicado: (2018)

Why data sharing is important for children
por: Choonara, Imti
Publicado: (2018)

Substandard medicines: a greater problem than counterfeit medicines?
por: Sammons, Helen M, et al.
Publicado: (2017)

Efficacy and Safety of Dulaglutide 3.0 mg and 4.5 mg Versus Dulaglutide 1.5 mg in Metformin-Treated Patients With Type 2 Diabetes in a Randomized Controlled Trial (AWARD-11)
por: Frias, Juan P., et al.
Publicado: (2021)

Exendin-(9-39) Effects on Glucose and Insulin in Children With Congenital Hyperinsulinism During Fasting and During a Meal and a Protein Challenge
por: Stefanovski, Darko, et al.
Publicado: (2022)

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial
por: Watada, Hirotaka, et al.
Publicado: (2020)

Valproic Acid and Fatalities in Children: A Review of Individual Case Safety Reports in VigiBase
por: Star, Kristina, et al.
Publicado: (2014)

Studying the Evolving Knowledge of Adverse Drug Reactions in Order to Facilitate the Rational Use of Medicines in Paediatric Patients
por: Star, Kristina, et al.
Publicado: (2019)

Substandard and counterfeit medicines: a systematic review of the literature
por: Almuzaini, Tariq, et al.
Publicado: (2013)

Setting the research agenda for women and children: the role of Health Technology Assessment
por: Choonara, Imti, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_kmrb425bkspumac7tnjhdib6gh